| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/1996 | US5539000 Spray-chilled nabumetone |
| 07/23/1996 | US5538997 2,4-diamino-3-hydroxycarboxylic acid derivatives |
| 07/23/1996 | US5538992 Potentiation of drug response |
| 07/23/1996 | US5538990 Benzimidazole anthelmintics |
| 07/23/1996 | US5538989 Fenbendazole formulations |
| 07/23/1996 | US5538986 Tricyclic derivatives, compositions and methods of use |
| 07/23/1996 | US5538984 Methods of using piperidyl-benzisoxazole and benisothiazole derivatives as cholinesterase inhibitors |
| 07/23/1996 | US5538983 Method of treating amyloidosis by modulation of calcium |
| 07/23/1996 | US5538982 Medical use for tachykinin antagonists |
| 07/23/1996 | US5538981 5-hydroxytryptamine receptor antagonist activity |
| 07/23/1996 | US5538980 Central nervous system |
| 07/23/1996 | US5538978 9-purinyl phosphonic acid derivatives |
| 07/23/1996 | US5538975 (-)-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5yl) -(1h)-pyrimidin-2-one and derivatives; antiviral agent |
| 07/23/1996 | US5538974 Ophthalmic composition for lowering intraocular pressure |
| 07/23/1996 | US5538972 Imidazoloquinoxalinones for the treatment of central nervous disorders |
| 07/23/1996 | US5538970 Treatment of cancer with imidazo-1,2-pyridazin compounds |
| 07/23/1996 | US5538969 4-amino derivatives of 5-substituted mycophenolic acid |
| 07/23/1996 | US5538968 Alzheimer's disease |
| 07/23/1996 | US5538965 Dopamine receptor ligands |
| 07/23/1996 | US5538963 Bactericide antibiotics |
| 07/23/1996 | US5538962 Penicillins |
| 07/23/1996 | US5538961 Macrocyclic lactam prokinetic agents |
| 07/23/1996 | US5538960 Hydrazono-5β, 14β-androstane derivatives active on the cardiovascular system, and pharmaceutical compositions containing same |
| 07/23/1996 | US5538959 Analgesic composition for treatment of migraine headaches |
| 07/23/1996 | US5538957 Phosphonosuccinic acid derivatives, processes for their preparation and medicaments containing these compounds |
| 07/23/1996 | US5538940 Fungicide, miticide, insecticide |
| 07/23/1996 | US5538883 Maltose-trehalose converting enzyme |
| 07/23/1996 | US5538740 Centrifuging gastropodes to get fluid and not kill snail, separation of fluid and supernatant, recovering filtrate |
| 07/23/1996 | US5538737 Water-in-oil emulsion in capsule form |
| 07/23/1996 | US5538734 5-methyltetrahydrofolic acid, 5-formyl-tetrahydrofolic acid and their pharmaceutically acceptable salts for use in the therapy of depressive disturbances |
| 07/23/1996 | US5538722 Isolation, growth, differentiation and genetic engineering of human muscle cells |
| 07/23/1996 | US5538721 Stabilization of aminosteroids for topical ophthalmic and other applications |
| 07/23/1996 | CA2054188C Inclusion complexes of n-ethoxycarbonyl-3-morpholino- sydnonimine or salts formed with cyclodextrin-derivatives, preparation thereof and pharmaceutical compositions containing thesame |
| 07/23/1996 | CA2021714C Liver function improver |
| 07/23/1996 | CA2001996C Method of treatment for interstitial cystitis |
| 07/23/1996 | CA1338484C 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use |
| 07/23/1996 | CA1338475C Stereospecific process for the preparation of furo ¬3,4-c| pyridine enantiomers and compounds thus obtained |
| 07/23/1996 | CA1338474C Pyridoindole derivatives and processes for preparation thereof |
| 07/23/1996 | CA1338473C Oxadiazolyl-azabicycloheptanes for the treatment of senile dementia |
| 07/23/1996 | CA1338467C Pharmaceutical composition, pharmaceutical granulate and process for their preparation |
| 07/21/1996 | CA2167472A1 Methods of inhibiting endometriosis |
| 07/21/1996 | CA2167469A1 Methods of inhibiting bone loss |
| 07/21/1996 | CA2167460A1 Methods for inhibiting uterine fibroid disease |
| 07/21/1996 | CA2167456A1 Use of l-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-a and other immunodeppresant drugs |
| 07/20/1996 | CA2167353A1 2,9-disubstituted purin-6-ones |
| 07/20/1996 | CA2167349A1 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 07/20/1996 | CA2167345A1 2,8-disubstituted quinazolinones |
| 07/18/1996 | WO1996021732A1 Il-2r-associated polypeptide and dna molecules coding therefor |
| 07/18/1996 | WO1996021731A2 Stabilized external guide sequences |
| 07/18/1996 | WO1996021674A1 Novel peptides, their production and use |
| 07/18/1996 | WO1996021670A2 Antifungal fusacandins |
| 07/18/1996 | WO1996021667A1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
| 07/18/1996 | WO1996021666A1 Camptothecin derivatives and its manufacturing method |
| 07/18/1996 | WO1996021663A1 IMIDAZO[4,5-c]QUINOLINE AMINES |
| 07/18/1996 | WO1996021662A1 THE USE OF HETEROCYCLIC COMPOUNDS AS ANTIOXIDANTS, RADICAL SCAVENGERS, Fe2+ COMPLEXING AGENTS, TISSUE- AND/OR NEUROPROTECTANTS |
| 07/18/1996 | WO1996021661A1 Piperidine derivatives having tachykinin antagonist activity |
| 07/18/1996 | WO1996021658A1 Hydrophobic taxane derivatives |
| 07/18/1996 | WO1996021656A1 Estrogen agonists/antagonists |
| 07/18/1996 | WO1996021655A2 Substituted oxazolidine calpain and/or cathepsin b inhibitors |
| 07/18/1996 | WO1996021654A1 Novel compounds |
| 07/18/1996 | WO1996021648A1 New piperazine derivatives and methods for the preparation thereof and compositions containing the same |
| 07/18/1996 | WO1996021644A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | WO1996021643A1 Antiarrhythmic (s)-enantiomers of methanesulfonamides |
| 07/18/1996 | WO1996021642A1 Process for the synthesis of cationic surfactants obtained from the condensation of fatty acids with esterified dibasic aminoacids, and their application as antimicrobial agents |
| 07/18/1996 | WO1996021641A1 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane |
| 07/18/1996 | WO1996021640A1 Optically active aminoindane derivatives and preparation thereof |
| 07/18/1996 | WO1996021638A1 Novel compounds |
| 07/18/1996 | WO1996021464A1 Compositions for the delivery of antigens |
| 07/18/1996 | WO1996021456A1 Inhibitors of prenyl transferases |
| 07/18/1996 | WO1996021454A1 Phosphate-binding polymers for oral administration |
| 07/18/1996 | WO1996021453A1 Enrofloxacine injection or infusion solutions |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | WO1996021451A1 Crystalline trimetrexate salts and the process for making the same |
| 07/18/1996 | WO1996021449A1 Pharmaceutical composition of indene derivatives for regulating apoptosis |
| 07/18/1996 | WO1996021448A1 Resin particle, medical material and pharmaceutical preparation containing said resin particle |
| 07/18/1996 | WO1996021447A1 Use of carbostyril compounds for inhibition of tnf-alpha |
| 07/18/1996 | WO1996021446A1 Pharmaceutical composition with anti-alcoholic and nootropic properties |
| 07/18/1996 | WO1996021445A1 Methods of inhibiting neurodegenerative diseases |
| 07/18/1996 | WO1996021444A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of gynaecological disorders |
| 07/18/1996 | WO1996021443A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment |
| 07/18/1996 | WO1996021442A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia |
| 07/18/1996 | WO1996021441A1 Methods of inhibiting growth hormone effects |
| 07/18/1996 | WO1996021440A1 Methods for increasing the bioavailability of biological active agents |
| 07/18/1996 | WO1996021439A1 Pharmaceutical composition containing fenofibrate and polyglycolized glycerides |
| 07/18/1996 | WO1996021438A1 Regulating gene expression using retinoids with ch2oh or related groups at the side chain terminal position |
| 07/18/1996 | WO1996021437A1 Treatment of movement disorders using large neutral amino acids |
| 07/18/1996 | WO1996021436A1 Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products |
| 07/18/1996 | WO1996021435A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 07/18/1996 | WO1996021434A1 Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts |
| 07/18/1996 | WO1996021433A1 Plaster containing estradiol |
| 07/18/1996 | WO1996021430A1 Treatment of attention-deficit/hyperactivity disorder |
| 07/18/1996 | WO1996021421A1 Nutrient medium for use as a culture medium for epidermal cells, and uses thereof |
| 07/18/1996 | WO1996021403A1 Dietary phytoestrogen in estrogen replacement therapy |
| 07/18/1996 | WO1996003122A3 Use of gabapentin in the treatment of anxiety and panic |
| 07/18/1996 | WO1996001613A3 Alcoholic moisturizing after shave lotion |
| 07/18/1996 | WO1996001253A3 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 07/18/1996 | WO1995033062A3 Method for introducing foreign matter into higher eukaryotic cells |
| 07/18/1996 | WO1995031981A3 Methods and compositions for reducing multidrug resistance |
| 07/18/1996 | DE19500990A1 Neues Peptid, seine Herstellung und Verwendung New peptide, its preparation and use |
| 07/18/1996 | DE19500784A1 Enrofloxacin-Injektions- oder Infusionslösungen Enrofloxacin injection or infusion solutions |